Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A combined ex vivo fundus imaging-histology protocol for clinicopathological validation of human donor eyes with limited medical history.

Scientific reports·2026
Same author

The iCre-DTA176 Mouse Exhibits Canonical Spontaneous Network Activity Associated With Retinal Degeneration.

Investigative ophthalmology & visual science·2026
Same author

Clinical Outcomes of a Prosthetic Capsular Bag for Scleral Fixation of an Intraocular Lens in Eyes without Capsular Support.

Ophthalmology·2026
Same author

Argon laser demarcation of AIDS-related cytomegalovirus retinitis in resource-limited setting.

International ophthalmology·2026
Same author

Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN study.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026
Same author

International consensuses and guidelines on diagnosing and managing fungal endophthalmitis by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO), and the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII).

Eye and vision (London, England)·2025

Related Experiment Video

Updated: May 24, 2025

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
07:13

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Published on: December 7, 2016

13.1K

The 1-Step Versus 2-Step Subretinal Injection Trial (1,2-SIT)-A Randomized Controlled Trial to Compare Drug Reflux

Matthew P Simunovic1, Zak J Prime2, Rhuen Chiou Chow2

  • 1From the Save Sight Institute (M.P.S. and L.K.T.), University of Sydney, Sydney, NSW, Australia; Sydney Eye Hospital (M.P.S., Z.J.P., R.C.C., E.H.S., Z.M., P.O., T.H.Y., K.T.O.), Sydney, NSW, Australia; Discipline of Surgery (M.P.S.), University of New South Wales, Sydney, Australia.

American Journal of Ophthalmology
|February 28, 2025
PubMed
Summary
This summary is machine-generated.

This study found that both 1-step and 2-step subretinal injections (SRI) result in similar drug loss, but the 2-step method offers more consistent delivery. Sodium fluorescein is suitable for tracking gene and cell therapies in the subretinal space.

More Related Videos

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes
12:45

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes

Published on: August 12, 2017

9.4K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

217

Related Experiment Videos

Last Updated: May 24, 2025

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
07:13

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Published on: December 7, 2016

13.1K
Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes
12:45

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes

Published on: August 12, 2017

9.4K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

217

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Drug Delivery

Background:

  • Subretinal injection (SRI) is a key method for delivering therapies to the retina.
  • Estimating drug retention in the subretinal space is crucial for optimizing treatment efficacy.
  • Variability in drug delivery can impact outcomes in retinal gene and cell therapies.

Purpose of the Study:

  • To quantify drug retention in the subretinal space following 1-step versus 2-step SRI in human subjects.
  • To evaluate the impact of sodium fluorescein as an optical label on drug delivery consistency.
  • To assess the compatibility of sodium fluorescein with adeno-associated viral (AAV) vectors and retinal progenitor cells (RPCs).

Main Methods:

  • A randomized controlled trial comparing 1-step and 2-step SRI in patients with submacular hemorrhage.
  • Subretinal injection of tissue plasminogen activator with sodium fluorescein as an optical tracer.
  • Fluorophotometry to measure drug reflux and quantitative PCR/cell viability assays to assess AAV and RPCs.
  • Intravitreal anti-VEGF injections and follow-up for 12 weeks.

Main Results:

  • Mean drug reflux was comparable between 1-step (4.8%) and 2-step (3.9%) SRI, with no significant difference in surgical duration, visual acuity, or foveal thickness.
  • A significantly greater variability in drug reflux was observed with the 1-step SRI method.
  • Sodium fluorescein did not affect AAV titers or RPC viability in vitro.

Conclusions:

  • Drug loss following SRI ranged from 0.4% to 19.8%, with a mean of 4.3%.
  • The 2-step SRI approach provides more consistent drug delivery compared to the 1-step method.
  • Sodium fluorescein is a suitable agent for quantitatively tracking subretinal AAV gene and cell therapies.